StockNews.AI
WGS
StockNews.AI
203 days

GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025

1. GeneDx will announce Q4 and full year 2024 results on February 18, 2025. 2. Management will host a conference call that morning at 8:30 a.m. ET. 3. Company focuses on genetic testing to improve health outcomes and accelerate drug discovery.

Earnings
-4.51%Current Return
VS
-0.45%S&P 500
$79.2401/28 05:42 PM EDTEvent Start
$75.6701/30 12:11 AM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Neutral?

The announcement of financial results typically does not drive significant immediate price changes.

How important is it?

Earnings reports can influence investor sentiment, though not always drastically.

Why Short Term?

Upcoming earnings announcements tend to have a short-term effect on stock prices.

Related Companies

WGSAMGNILMN
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced it will release financial results for the fourth quarter 2024 and the full year 2024 before the market opens on Tuesday, February 18, 2025. Management will host a conference call that day to discuss fourth quarter 2024 and full year 2024 financial and operating results at 8:30 a.m. Eastern Time. Conference Call Details Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the “Events” section of the GeneDx investor relations website at https://ir.genedx.com/. About GeneDx At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. For more information, please visit genedx.com and connect with us on LinkedIn, Facebook, and Instagram.

Related News